Exicure, Inc. announced that on January 5, 2021, R. Venkatesan, M.D., a member of the Company's board of directors and chairperson of the Audit Committee of the Board has resigned from the Company's Board and the Audit Committee of the Board, effective December 29, 2020. Dr. Venkatesan's resignation is not the result of any disagreement with the Company on any matter relating to the Company's operations, policies, or practices. Upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed James Sulat to serve as a director of the Company and chairperson of the Audit Committee, effective January 2, 2021. Mr. Sulat will serve for the term expiring at the Company's 2023 annual meeting of stockholders, and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.